If you are a healthcare provider and wish to order monoclonal antibody products, please see the guidance below.
Monoclonal antibody (mAb) products are available in the United States under an Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA) for early treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in patients who are at high risk for progression to severe COVID-19 and/or hospitalization or death. REGEN-COV is also authorized for post-exposure prophylaxis.*
* Note: Post-exposure prophylaxis with REGEN-COV is not a substitute for vaccination against COVID-19, and REGEN-COV is not authorized for pre-exposure prophylaxis.
Required Reporting
In order to continue to receive product, you must report weekly utilization to HHS and MSDH.
- To register your site for HHS reporting, e-mail hhs-protect@teletracking.com.
- To register your site for MSDH reporting, e-mail your contact information to monoclonals@msdh.ms.gov.
EUA Fact Sheets
Please see full EUAs from the FDA:
- Fact Sheet for Health Care Providers Emergency Use Authorization of REGEN-COV (casirivimab and imdevimab) FDA
- Fact Sheet for Health Care Providers Emergency Use Authorization of Bamlanivimab and Etesevimab 08272021 FDA
- GSK Sotrovimab Fact Sheet for HCP 07092021 FDA
Ordering REGEN-COV (Regeneron)
- Purchased by the U.S. Department of Health and Human Services
- If you are an existing monoclonal antibody provider and would like to request an order, you will need to fill out the quantity requested on the Monoclonal Antibody REDCap Survey sent from MSDH to your facility each Wednesday. If you have not received the link to this survey, please e-mail monoclonals@msdh.ms.gov.
Ordering Sotrovimab (GlaxoSmithKline)
- Customers must purchase through AmerisourceBergen
Ordering Bamlanivimab/etesevimab (Eli Lilly)
DISTRIBUTION AND UTILIZATION RESUMED
- Purchased by the U.S. Department of Health and Human Services
- If you are an existing monoclonal antibody provider and would like to request an order, you will need to fill out the quantity requested on the Monoclonal Antibody REDCap Survey sent from MSDH to your facility each Wednesday. If you have not received the link to this survey, please e-mail monoclonals@msdh.ms.gov.
If you have questions, please send e-mail to monoclonals@msdh.ms.gov

